Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-021327
Filing Date
2019-10-29
Accepted
2019-10-29 06:02:29
Documents
5
Period of Report
2019-10-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k102919_immuronlimited.htm 6-K 12193
2 IMMURON FILED XBRL DATA WITH THE SEC f6k102919ex99-1_immuron.htm EX-99.1 6632
3 GRAPHIC image_001.jpg GRAPHIC 2985
4 GRAPHIC ex99-1_001.jpg GRAPHIC 17725
5 GRAPHIC ex99-1_002.jpg GRAPHIC 20787
  Complete submission text file 0001213900-19-021327.txt   77403
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 191174384
SIC: 2834 Pharmaceutical Preparations